Holguín with the second lowest infant mortality rate in Cuba
- Written by Lourdes Pichs Rodríguez
- Category: Health
- Hits: 1103
Scientists from the Center for Genetic Engineering and Biotechnology (CIGB) together with researchers from the Cuban health system have been developing for a decade a promising vaccine candidate HeberSaVax to guarantee the survival of patients with liver cancer or hepatocarcinoma, a pathology that annually causes more than half a million deaths worldwide.